Jim Cramer's Best Blogs

lot of money doing what they do. Ironically, it is a godsend to the health care reform enemy Wellpoint(WLP), which we have been buying for our charitable trust. The tone has changed for generics, for biotechs -- where Celgene(CELG) is really cheap and...